Xcout Intel
StratifAI
StratifAI is a precision oncology company developing the next generation of biomarkers to advance cancer diagnostics using its Polaris discovery platform. The company is headquartered in Berlin, Germany.
Subscribe to see StratifAI’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
StratifAI at a glance
StratifAI is an artificial intelligence company headquartered in Germany. Its most recent funding round, Pre-Seed, closed in September 2025. Xcout tracks 1 named person at StratifAI, including Omar El Nahhas (CEO and co-founder).
StratifAI leadership
- Omar El NahhasCEO and co-founder
StratifAI funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | Undisclosed | 7 named | |
| Pre-Seed | Undisclosed | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
StratifAI competitors
A few of StratifAI's closest competitors — see the full list of competitors and alternatives →
Pangea Biomed, founded in 2018 and headquartered in Tel Aviv, Israel, is a biotechnology company focused on cancer. Its mission is to democratize precision oncology, bringing deep tumor intelligence to drug development and treatment nomination.
Ataraxis AI is an artificial intelligence company headquartered in New York that links AI model predictions to real patient outcomes across oncology.
Cellyrix Therapeutics is a biotechnology company founded in 2024 and headquartered in Rehovot, Israel. The company leverages single-cell RNA sequencing and artificial intelligence to develop cancer treatments by addressing tumor heterogeneity and cell-state modulation.
PreciseDx, Inc. provides an AI-powered platform called OncoIntelligence and its specific product, PreciseBreast, to analyze tissue samples and determine breast cancer recurrence risk. The company serves oncologists, surgeons, pathologists, payors, and patients by offering objective risk stratification and phenotype insights within hours.
Get StratifAI's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on StratifAI in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access